300 related articles for article (PubMed ID: 35673559)
41. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
42. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
[TBL] [Abstract][Full Text] [Related]
43. Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer.
Yu H; Bai K; Cheng Y; Lv J; Song Q; Yang H; Lu Q; Yang X
Aging (Albany NY); 2023 Jul; 15(13):6302-6330. PubMed ID: 37414093
[TBL] [Abstract][Full Text] [Related]
44. Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer.
Luo WJ; Tian X; Xu WH; Qu YY; Zhu WK; Wu J; Ma CG; Zhang HL; Ye DW; Zhu YP
J Cell Mol Med; 2021 May; 25(9):4326-4339. PubMed ID: 33797188
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
Li H; Zhang Y; Zheng S
Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
[TBL] [Abstract][Full Text] [Related]
46. APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy.
Boichard A; Pham TV; Yeerna H; Goodman A; Tamayo P; Lippman S; Frampton GM; Tsigelny IF; Kurzrock R
Oncoimmunology; 2019; 8(3):1550341. PubMed ID: 30723579
[TBL] [Abstract][Full Text] [Related]
47. Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients.
Chen H; Yang W; Ji Z
Front Immunol; 2023; 14():1171420. PubMed ID: 37063886
[TBL] [Abstract][Full Text] [Related]
48. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
Zhang Y; Delahanty R; Guo X; Zheng W; Long J
Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
[TBL] [Abstract][Full Text] [Related]
49. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
[TBL] [Abstract][Full Text] [Related]
50. Development of a butyrate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis and immunotherapy response in bladder cancer.
Yuan P; Li S; Xiong S; Zheng F; Yang L; Jiang M; Liu J; Liu X; Deng J; Zeng J; Fu B
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12489-12505. PubMed ID: 37450031
[TBL] [Abstract][Full Text] [Related]
51. 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer.
Hu J; Othmane B; Yu A; Li H; Cai Z; Chen X; Ren W; Chen J; Zu X
BMC Med; 2021 Nov; 19(1):289. PubMed ID: 34836536
[TBL] [Abstract][Full Text] [Related]
52. G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer.
Duan L; Liu X; Luo Z; Zhang C; Wu C; Mu W; Zuo Z; Pei X; Shao T
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456499
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression.
Du Y; Cao J; Jiang X; Cai X; Wang B; Wang Y; Wang X; Xue B
Cancer Cell Int; 2021 Nov; 21(1):613. PubMed ID: 34801033
[TBL] [Abstract][Full Text] [Related]
54. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
55. Combined single-cell RNA-seq and bulk RNA-seq to analyze the expression and role of TREM2 in bladder cancer.
Zhang X; Du Y; Xiong W; Shang P
Med Oncol; 2022 Nov; 40(1):23. PubMed ID: 36445493
[TBL] [Abstract][Full Text] [Related]
56. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.
Middlebrooks CD; Banday AR; Matsuda K; Udquim KI; Onabajo OO; Paquin A; Figueroa JD; Zhu B; Koutros S; Kubo M; Shuin T; Freedman ND; Kogevinas M; Malats N; Chanock SJ; Garcia-Closas M; Silverman DT; Rothman N; Prokunina-Olsson L
Nat Genet; 2016 Nov; 48(11):1330-1338. PubMed ID: 27643540
[TBL] [Abstract][Full Text] [Related]
57. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
Venkatesan S; Rosenthal R; Kanu N; McGranahan N; Bartek J; Quezada SA; Hare J; Harris RS; Swanton C
Ann Oncol; 2018 Mar; 29(3):563-572. PubMed ID: 29324969
[TBL] [Abstract][Full Text] [Related]
58. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
59. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z
Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211
[No Abstract] [Full Text] [Related]
60. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
